Drugs that contain Terazosin Hydrochloride
1. Hytrin patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5412095 | ABBOTT | Terazosin monohydrochloride and processes and intermediate for its production |
Apr, 2013
(11 years ago) | |
| US5294615 | ABBOTT | Terazosin polymorph and pharmaceutical composition |
Apr, 2013
(11 years ago) | |
Market Authorisation Date: 07 August, 1987
Treatment: Treatment of symptomatic benign prostatic hyperplasia
Dosage: TABLET;ORAL; CAPSULE;ORAL
How can I launch a generic of HYTRIN before it's drug patent expiration?
More Information on Dosage
HYTRIN family patents
